SEC Form 4 · accession 0001246360-18-001072
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey H Burbank
Officer — Chief Executive Officer · Director
Period of report
Mar 9, 2018
Accepted (ET)
Mar 12, 2018 · 4:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 9, 2018 | M | 17,464 | $0.00 | A | 778,579 | D | |
| Common Stock | Mar 9, 2018 | F | 5,167 | $24.37 | D | 773,412 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1 | $0.00 | Mar 9, 2018 | A | 52,392 | A | Mar 9, 2018 | Mar 9, 2020 | Common Stock | 52,392 | 52,392 | D |
| Restricted Stock Unit | $0.00 | Mar 9, 2018 | M | 17,464 | D | Mar 9, 2018 | Mar 9, 2020 | Common Stock | 17,464 | 34,928 | D |
Explanation of responses
- F1Award granted pursuant to the 2017 Performance Share Plan, vesting in 3 equal annual installments beginning March 9, 2018.